Boz, C.Terzi, M.Özakbaş, S.Yüceyar, N.Efendi, H.Balcı, B. P.Türkoğlu, R.Karabudak, R.Soysal, A.Yetkin, M. F.Kurne, A.Akcali, A.Akman, G.Demirkiran, M.Sevim, S.Kıyıoğlu, N.Çilingir, V.Köseoğlu, M.Uzuner, G.Ömerhoca, S.Turan, Ömer FarukKızılay, F.2024-12-022024-12-022019-09-011352-4585https://hdl.handle.net/11452/48763Bu çalışma, 11-13, Eylül 2019 tarihlerinde Location Stockholm[İsveç]’de düzenlenen 35. Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS Kongresi‘nde bildiri olarak sunulmuştur.eninfo:eu-repo/semantics/closedAccessScience & technologyLife sciences & biomedicineClinical neurologyNeurosciencesNeurosciences & neurologyReal world efficacy and safety of teriflunomide in multiple sclerosis: An observational study with four years follow-upMeeting Abstract000485303103364870870251477-0970